wondr health glp-1 support Cost Control Strategy for Employers Wondr Plus
Description
For some digestive systems, this pattern feels gentler and easier to tolerate
They lost about 4.8% more weight on average than those who took a fake pill (placebo)
G., Kobayashi, R., et al
Dual GLP1 and GIP agonists Tirzepatide is a once weekly, subcutaneous, unimolecular dual RA (GLP-1 and GIP) which has comparable GIP receptor binding affinity to native GIP and 5 times lower GLP-1 receptor affinity than that of native GLP-1
Its partnership model with Boehringer Ingelheim shows how metabolic disease innovation can move through collaboration rather than full acquisition
[DOI] [PubMed] [Google Scholar] 45
